More SEC Filings
View Older Stories View Newer Stories-
Form ARS HERBALIFE LTD. For: Dec 31
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form S-8 DocGo Inc.
-
Form 424B2 UBS AG
-
Form D Skyline Prime Limited
-
Form 4 GRANITE CONSTRUCTION For: Mar 13 Filed by: Estes Bradly J
-
Form 424B2 UBS AG
-
Form DEF 14A Farmland Partners Inc. For: Apr 28
-
Form 144 EverCommerce Inc. Filed by: Remer Eric Richard
-
Form 4 GRANITE CONSTRUCTION For: Mar 13 Filed by: Williams Bradley Jay
-
Form 144 EBAY INC Filed by: Rawashdeh Mazen
-
Form 4 QUAKER CHEMICAL CORP For: Mar 15 Filed by: Bijlani Jeewat
-
Form 4 FIRST BUSEY CORP /NV/ For: Mar 16 Filed by: Cassens Michael David
-
Form 4 WELLS FARGO & COMPANY/MN For: Mar 16 Filed by: Rivas Fernando
-
Form 144 Klaviyo, Inc. Filed by: Rowland Stephen Eric
-
Form 8-K Dare Bioscience, Inc. For: Mar 16
-
Form 8-K Traeger, Inc. For: Mar 17
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 424B2 UBS AG
-
Form D/A Keystone Energy Fund
-
Form 424B2 UBS AG
-
Form 424B2 BANK OF NOVA SCOTIA
-
Form 10-K Crestline Lending Soluti For: Dec 31
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 424B2 UBS AG
-
Form 424B2 UBS AG
-
Form 424B2 UBS AG
-
Form 424B2 UBS AG
-
Form 424B2 UBS AG
-
Form 144 Castellum, Inc. Filed by: McMillen Charles Thomas
-
Form 424B2 UBS AG
-
Form 424B2 UBS AG
-
Form 4 GRANITE CONSTRUCTION For: Mar 13 Filed by: Tatusko Michael G
-
Form 144 Navitas Semiconductor Filed by: GLICKMAN TODD
-
Form D Strand Therapeutics Inc.
-
Form 4 AUDIOEYE INC For: Mar 13 Filed by: Georgevich Kelly
-
Form 424B2 UBS AG
-
Form 424B2 UBS AG
-
Form 144 Bloom Energy Corp Filed by: SODERBERG SHAWN MARIE
-
Form 4 VEECO INSTRUMENTS INC For: Mar 13 Filed by: Porshnev Peter
-
Form 4 GRANITE CONSTRUCTION For: Mar 13 Filed by: WOOLSEY STACI M
-
Form 144 CURTISS WRIGHT CORP Filed by: Watts John C
-
Form DEFA14A JANUS HENDERSON GROUP
-
Form 4 Samsara Inc. For: Mar 16 Filed by: Chadwick Jonathan
-
Form 424B2 UBS AG
-
Form 424B2 UBS AG
-
Form 8-K Fulgent Genetics, Inc. For: Mar 17
-
Form 424B2 UBS AG
-
Form 4 Tarsus Pharmaceuticals, For: Mar 15 Filed by: Neervannan Seshadri

